Human Endogenous Retroviruses-K (HML-2) Expression Is Correlated with Prognosis and Progress of Hepatocellular Carcinoma
Table 1
Association of HERV-K expression with clinical parameters in HCC.
Characteristics
HERV-K relative expression (−log)
Mean ± SD
Tissue
−8.224
<0.001
HCC
84
5.94 ± 0.83
Adjacent noncancerous liver
84
6.49 ± 0.72
Gender
0.306
0.240
Male
78
5.95 ± 0.86
Female
6
5.84 ± 0.32
Age
−0.130
0.320
<55
40
5.84 ± 1.00
≧55
44
6.02 ± 0.67
Smoking
1.280
0.204
Negative
43
6.05 ± 0.69
Positive
41
5.82 ± 0.95
Alcoholism
1.662
0.100
Negative
25
5.70 ± 1.18
Positive
59
6.03 ± 0.63
Differentiation
2.601
0.011
High/moderate
59
6.05 ± 0.68
Low
15
5.43 ± 1.23
Missing
10
Size
1.693
0.095
<10 cm
53
6.01 ± 0.85
≧10 cm
23
5.66 ± 0.76
Missing
8
Tumor nodes
−0.728
0.469
Single
66
5.91 ± 0.88
Multi
10
6.12 ± 0.61
Missing
8
TNM stage
2.144
0.035
I~II
34
6.12 ± 0.78
III~IV
42
5.72 ± 0.84
Missing
8
HBV DNA (IU/mL)
0.861
0.394
<500
17
5.90 ± 0.68
≧500
34
5.68 ± 0.95
Missing
33
Cirrhosis
−2.181
0.044
Negative
34
6.11 ± 0.65
Positive
14
5.39 ± 1.17
Missing
36
AFP (ng/mL)
−0.137
0.891
<200
41
5.93 ± 0.94
≧200
35
5.95 ± 0.75
Missing
8
ALT (u/L)
0.958
0.341
<46
48
6.00 ± 0.76
≧46
32
5.81 ± 0.96
Missing
4
AST (u/L)
0.642
0.523
<46
45
5.97 ± 0.66
≧46
35
5.86 ± 1.04
Missing
4
Data are mean ± SD. and . A paired -test was used with the analysis of the differences between HCC and adjacent noncancerous liver. Independent -tests were applied to the rest of data.